Expert Review of Pharmacoeconomics & Outcomes Research [ISSN 1473-7167]; [e-ISSN 1744-8379] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original research papers on health economics, pharmacoeconomics and outcomes, relating to all health technologies including; drugs, therapeutic approaches, medical devices, and prevention.

Articles focus on the following key areas:

    Health technology assessment and health economics
    Health economic evaluation (cost-effectiveness), pharmacoeconomics and budget impact analyses
    Outcomes research including therapeutic outcomes and health preference research
    Quality of life, economic burden and cost of illness.


The journal welcomes submissions of Original Research, Reviews, Systematic Reviews, Meta-analyses, Editorials and more. For guidelines on preparing each article type, please visit the instructions for authors page.

Each review article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Comprehensive coverage in each review is complemented by the unique Expert Collection format which includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.

Article Highlights – an executive summary of the author’s most critical points.

We welcome suggestions or recommendations for Editorials, Perspectives, Special Reports or Reviews for publication in Expert Review of Pharmacoeconomics & Outcomes Research. In the first instance, please contact the Commissioning Editor.

The journal supports the progress of the United Nations Sustainable Development Goals (SDGs) and welcomes submissions which align with and hold implications for the SDGs. Research in this journal is particularly relevant to the following SDGs:

Goal 3: Ensure healthy lives and promote well-being for all at all ages

Goal 8: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Pharmacoeconomics and Outcomes Research, part of the Expert Collection brand.

Senior Editor
Annemans L, University of Ghent, Belgium   
  
Associate Editors 
Cleeland C, MD Anderson Cancer Center, TX, USA 
Flechtner H-H, University of Magdeburg, Germany 
Gotay C, University of British Columbia, Canada 
Taphoorn MJB, Medical Centre Haaglanden, The Netherlands
Editorial Board
Aaronson NK, The Netherlands Cancer Institute, The Netherlands 
Ashcroft DM, University of Manchester, UK 
Awad AG, Humber River Regional Hospital, Toronto, Canada 
Badia X, IMS Health, Spain 
Bottomley A, EORTC, Belgium  
Bridges J, Ohio State University College of Medicine, Columbus, OH 
Brixner D, University of Utah, UT, USA 
Cella D, Northwesern University, IL, USA 
Chow E, Sunnybrook Regional Cancer Center, CA, USA 
Coens C, EORTC, Belgium 
Darba J, University of Barcelona, Spain 
DeKoven MP, IMS Health, Inc., VA, USA 
Fatoye F, Manchester Metropolitan University, Manchester, UK 
Ferreira PL, Universidade Coimbra, Portugal 
Gans-Combe C, Reihoo, France 
Garattini L, CESAV - Mario Negri Institute, Italy 
Garg V, Abbvie, IL, USA 
Greimel E, University of Graz, Austria 
Hartzema AG, University of Florida, FL, USA 
Hiligsmann M, Maastricht University, The Netherlands 
Ikegami N, Keio University, Japan 
Jakovljevic M, University of Kragujevac, Serbia 
Khan ZM, Celgene Corporation, NJ, USA 
King M, University of Sydney, Australia 
Krabbe PFM, University Medical Center Groningen, The Netherlands 
LeGrand C, Univ. Catholique de Louvain, Belgium 
Mendoza RL, Wilmington University, DE, USA 
Minshall ME, Strategic Consulting & Outcomes Research, IN, USA 
Motheral B, Artemetrx LLC., TN, USA 
Neumann PJ, Tufts University School of Medicine, MA, USA 
Pavlovic-Ganascia M, AFSSAPS, France 
Postma M, Groningen University, The Netherlands 
Raisch DW, University of New Mexico, NM, USA 
Ramjiawan B, St Boniface General Hospital Research Centre, Canada 
Ramsey S, Fred Hutchinson Cancer Research Center, WA, USA 
Rubenstein LZ, University of Oklahoma College of Medicine, USA 
Sankaranarayanan J, University of Connecticut, USA 
Sculpher M, University of York, UK 
Sendi P, University of Basel, Switzerland 
Shaya FT, University of Maryland, MD, USA 
Simoens S, Katholieke Universiteit Leuven, Belgium 
Sloan J, Mayo Clinic/Medical School, MN, USA 
Summers KH, Astellas Pharma, IL, USA 
Wilson L, University of California San Francisco, CA, USA 
Younis MZ, Jackson State University, FL, USA 
Yfantopoulos J, University of Athens, Greece